SRPT
Sarepta Therapeutics, Inc.
Company overview
- Market capitalization
- $1.99B
- Employees
- 835
- Latest publication
- 2026-09-29
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q2 20252025-06-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q2 20172017-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 730,803,000USD | 611,091,000USD | 658,412,000USD | 467,172,000USD | 362,931,000USD | 413,464,000USD | 396,781,000USD | 35,011,000USD |
| Cost Of Revenue | 119,362,000USD | 152,558,000USD | 132,304,000USD | 91,691,000USD | 44,545,000USD | 50,559,000USD | 44,176,000USD | 534,000USD |
| Gross Profit | 611,441,000USD | 458,533,000USD | 526,108,000USD | 375,481,000USD | 318,386,000USD | 362,905,000USD | 352,605,000USD | 34,477,000USD |
| Research Development | 153,960,000USD | 204,392,000USD | 199,953,000USD | 224,483,000USD | 179,690,000USD | 200,396,000USD | 195,517,000USD | 58,908,000USD |
| Selling General Administrative | 108,951,000USD | 137,897,000USD | 163,873,000USD | 128,200,000USD | 138,796,000USD | 127,003,000USD | 131,700,000USD | 33,649,000USD |
| Unclassified Operating Expenses | -9,903,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 253,008,000USD | 342,956,000USD | 364,427,000USD | 353,285,000USD | 319,087,000USD | 328,000,000USD | 327,980,000USD | 94,977,000USD |
| Operating Income | 358,433,000USD | 115,577,000USD | 161,681,000USD | 22,196,000USD | -701,000USD | 34,905,000USD | 24,625,000USD | -63,339,000USD |
| Interest Income | 7,002,000USD | 7,141,000USD | 14,695,000USD | 18,333,000USD | 18,842,000USD | 19,897,000USD | 22,628,000USD | — |
| Interest Expense | 21,713,000USD | 5,228,000USD | 4,475,000USD | 4,918,000USD | 4,832,000USD | 4,166,000USD | 5,234,000USD | 265,000USD |
| Net Interest Income | -14,711,000USD | 1,913,000USD | 10,220,000USD | 13,415,000USD | 14,010,000USD | 15,731,000USD | 17,394,000USD | — |
| Income Before Tax | 343,174,000USD | 153,638,000USD | 171,743,000USD | 34,006,000USD | 13,577,000USD | 41,448,000USD | 40,371,000USD | -63,155,000USD |
| Income Tax Expense | 12,215,000USD | -43,254,000USD | 12,694,000USD | 395,000USD | 7,117,000USD | 5,329,000USD | -5,284,000USD | -109,000USD |
| Tax Provision | 12,215,000USD | -43,254,000USD | 12,694,000USD | 395,000USD | 7,117,000USD | 5,329,000USD | -5,284,000USD | — |
| Net Income | 330,959,000USD | 196,892,000USD | 159,049,000USD | 33,611,000USD | 6,460,000USD | 36,119,000USD | 45,655,000USD | -63,046,000USD |
| Net Income From Continuing Ops | 330,959,000USD | 196,892,000USD | 159,049,000USD | 33,611,000USD | 6,460,000USD | 36,119,000USD | 45,655,000USD | -63,046,000USD |
| Ebit | 364,887,000USD | 158,866,000USD | 176,218,000USD | 38,924,000USD | 18,409,000USD | 45,614,000USD | 45,605,000USD | -63,155,000USD |
| Ebitda | 375,481,000USD | 169,706,000USD | 186,673,000USD | 48,730,000USD | 27,128,000USD | 54,358,000USD | 56,977,000USD | -61,383,000USD |
| Depreciation And Amortization | 10,594,000USD | 10,840,000USD | 10,455,000USD | 9,806,000USD | 8,719,000USD | 8,744,000USD | 11,372,000USD | 1,772,000USD |
| Reconciled Depreciation | 10,594,000USD | 10,840,000USD | 10,455,000USD | 9,806,000USD | 8,719,000USD | 8,744,000USD | 11,372,000USD | 1,772,000USD |
| Total Other Income Expense Net | -15,259,000USD | 38,061,000USD | 10,062,000USD | 11,810,000USD | 14,278,000USD | 6,543,000USD | 15,746,000USD | 184,000USD |
| Selling And Marketing Expenses | — | — | — | — | 2,136,000USD | — | — | 2,420,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 184,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -63,046,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20062006-12-31 · USD | FY 20052005-12-31 · USD | FY 20042004-12-31 · USD | FY 20002000-12-31 · USD | FY 19991999-12-31 · USD | FY 19971997-12-31 · USD | FY 19961996-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,901,979,000USD | 115,291USD | 4,783,760USD | 430,461USD | 1,297,338USD | 100,000USD | 100,000USD | 100,000USD |
| Cost Of Revenue | 319,099,000USD | 31,009,000USD | 20,302,000USD | 23,586,000USD | -416,497USD | — | -500,000USD | -500,000USD |
| Gross Profit | 1,582,880,000USD | 115,291USD | 4,783,760USD | 430,461USD | 1,713,835USD | 100,000USD | 600,000USD | 600,000USD |
| Research Development | 804,522,000USD | 25,345,588USD | 17,117,750USD | 20,738,725USD | 9,268,330USD | 6,700,000USD | 2,700,000USD | 1,700,000USD |
| Selling General Administrative | 557,872,000USD | 7,752,752USD | 5,182,369USD | 4,735,731USD | 2,270,302USD | 1,700,000USD | 1,300,000USD | 600,000USD |
| Total Operating Expenses | 1,364,799,000USD | 33,098,340USD | 22,300,119USD | 25,474,456USD | 11,955,129USD | 8,400,000USD | 4,500,000USD | 2,800,000USD |
| Operating Income | 218,081,000USD | -32,983,049USD | -17,516,359USD | -25,043,995USD | -10,241,294USD | -8,300,000USD | -3,900,000USD | -2,200,000USD |
| Interest Income | 71,767,000USD | — | — | — | — | — | — | — |
| Interest Expense | 18,391,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Interest Income | 53,376,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 260,774,000USD | -31,073,012USD | -16,675,864USD | -24,777,694USD | -9,239,956USD | -8,400,000USD | -3,500,000USD | -2,000,000USD |
| Income Tax Expense | 25,535,000USD | — | — | — | — | — | -300,000USD | 100,000USD |
| Tax Provision | 25,535,000USD | — | — | — | — | — | — | — |
| Net Income | 235,239,000USD | -31,073,012USD | -16,675,864USD | -24,777,694USD | -9,239,956USD | -8,300,000USD | -3,600,000USD | -2,100,000USD |
| Net Income From Continuing Ops | 235,239,000USD | — | — | — | — | — | — | — |
| Ebit | 279,165,000USD | -32,983,049USD | -16,675,864USD | -24,777,694USD | -10,241,294USD | -8,300,000USD | -3,900,000USD | -2,200,000USD |
| Ebitda | 316,889,000USD | -30,892,674USD | -14,678,192USD | -22,889,686USD | -9,824,797USD | -8,000,000USD | -3,400,000USD | -1,700,000USD |
| Depreciation And Amortization | 37,724,000USD | 2,090,375USD | 1,997,672USD | 1,888,008USD | 416,497USD | 300,000USD | 500,000USD | 500,000USD |
| Reconciled Depreciation | 37,724,000USD | — | — | — | — | — | — | — |
| Total Other Income Expense Net | 42,693,000USD | 1,910,037USD | 840,495USD | 266,301USD | 1,001,338USD | -100,000USD | 400,000USD | 200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,178,934,000USD | 3,349,703,000USD | 3,493,437,000USD | 3,679,814,000USD | 3,465,387,000USD | 3,963,173,000USD | 3,599,934,000USD | 3,424,257,000USD |
| Intangible Assets | 31,384,000USD | 28,949,000USD | 29,684,000USD | 30,522,000USD | 26,199,000USD | 26,887,000USD | 27,570,000USD | 28,252,000USD |
| Other Current Assets | 107,663,000USD | 163,934,000USD | 252,546,000USD | 253,215,000USD | 243,815,000USD | 318,983,000USD | 405,069,000USD | 345,107,000USD |
| Total Liab | 1,673,832,000USD | 2,209,081,000USD | 2,173,317,000USD | 2,322,429,000USD | 2,322,664,000USD | 2,435,431,000USD | 2,378,863,000USD | 2,347,188,000USD |
| Total Stockholder Equity | 1,505,102,000USD | 1,140,622,000USD | 1,320,120,000USD | 1,357,385,000USD | 1,142,723,000USD | 1,527,742,000USD | 1,221,071,000USD | 1,077,069,000USD |
| Other Current Liab | 312,751,000USD | 359,659,000USD | 341,961,000USD | 369,085,000USD | 324,760,000USD | 356,122,000USD | 347,423,000USD | 349,346,000USD |
| Common Stock | 11,000USD | 11,000USD | 11,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD |
| Capital Stock | 11,000USD | 11,000USD | 11,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD |
| Retained Earnings | -4,546,025,000USD | -4,876,984,000USD | -4,641,537,000USD | -4,461,590,000USD | -4,658,482,000USD | -4,210,974,000USD | -4,370,023,000USD | -4,403,634,000USD |
| Cash | 464,450,000USD | 801,282,000USD | 613,077,000USD | 510,598,000USD | 240,867,000USD | 1,103,010,000USD | 197,855,000USD | 383,622,000USD |
| Cash And Short Term Investments | 653,189,000USD | 939,650,000USD | 850,993,000USD | 800,139,000USD | 522,762,000USD | 1,354,792,000USD | 1,198,389,000USD | 1,460,474,000USD |
| Total Current Assets | 2,309,876,000USD | 2,537,938,000USD | 2,722,309,000USD | 2,656,985,000USD | 2,432,533,000USD | 3,073,463,000USD | 2,685,369,000USD | 2,683,636,000USD |
| Total Current Liabilities | 499,164,000USD | 1,095,290,000USD | 921,425,000USD | 919,948,000USD | 605,588,000USD | 731,684,000USD | 699,489,000USD | 688,490,000USD |
| Current Deferred Revenue | 116,037,000USD | 443,397,000USD | 485,449,000USD | 395,431,000USD | 44,859,000USD | 130,256,000USD | 127,001,000USD | 122,036,000USD |
| Net Debt | 572,216,999USD | 238,463,000USD | 637,111,000USD | 843,279,000USD | 1,102,882,000USD | 240,060,000USD | 1,199,714,000USD | 986,294,000USD |
| Short Long Term Debt Total | 1,036,666,999USD | 1,039,745,000USD | 1,250,188,000USD | 1,353,877,000USD | 1,343,749,000USD | 1,343,070,000USD | 1,397,569,000USD | 1,369,916,000USD |
| Long Term Debt | 838,162,000USD | 828,974,000USD | 1,035,146,000USD | 1,139,458,000USD | 1,138,289,000USD | 1,137,124,000USD | 1,135,965,000USD | 1,134,810,000USD |
| Long Term Investments | 89,731,000USD | 10,568,000USD | 9,205,000USD | 34,604,000USD | 109,125,000USD | 136,873,000USD | 186,493,000USD | 7,606,000USD |
| Short Term Investments | 188,739,000USD | 138,368,000USD | 237,916,000USD | 289,541,000USD | 281,895,000USD | 251,782,000USD | 1,000,534,000USD | 1,076,852,000USD |
| Net Receivables | 547,912,000USD | 519,610,000USD | 541,604,000USD | 609,595,000USD | 724,524,000USD | 649,728,000USD | 515,987,000USD | 392,260,000USD |
| Inventory | 1,001,112,000USD | 914,744,000USD | 1,077,166,000USD | 994,036,000USD | 941,432,000USD | 749,960,000USD | 565,924,000USD | 485,795,000USD |
| Accounts Payable | 70,376,000USD | 280,841,000USD | 94,015,000USD | 136,702,000USD | 156,105,000USD | 214,442,000USD | 118,774,000USD | 107,417,000USD |
| Property Plant Equipment Net | 460,300,000USD | 470,620,000USD | 498,103,000USD | 514,898,000USD | 507,650,000USD | 488,646,000USD | 446,686,000USD | 400,201,000USD |
| Property Plant Equipment Gross | 460,300,000USD | 751,535,000USD | 498,103,000USD | 514,898,000USD | 507,650,000USD | 722,791,000USD | 446,686,000USD | 400,201,000USD |
| Accumulated Other Comprehensive Income | -121,000USD | 272,000USD | 220,000USD | -51,000USD | 34,000USD | -218,000USD | 2,245,000USD | -1,030,000USD |
| Common Stock Shares Outstanding | 121,916,000shares | 104,793,000shares | 100,237,000shares | 106,623,000shares | 97,362,000shares | 108,474,000shares | 100,448,000shares | 99,144,000shares |
| Non Current Assets Total | 869,058,000USD | 811,765,000USD | 771,128,000USD | 1,022,829,000USD | 1,032,854,000USD | 889,710,000USD | 914,565,000USD | 740,621,000USD |
| Non Current Liabilities Total | 1,174,668,000USD | 1,113,791,000USD | 1,251,892,000USD | 1,402,481,000USD | 1,717,076,000USD | 1,703,747,000USD | 1,679,374,000USD | 1,658,698,000USD |
| Non Current Liabilities Other | 1,647,000USD | 1,529,000USD | 1,704,000USD | 48,604,000USD | 48,327,000USD | 49,150,000USD | 48,400,000USD | 55,287,000USD |
| Non Currrent Assets Other | 271,710,000USD | 311,148,000USD | 231,861,000USD | 442,805,000USD | 389,880,000USD | 237,304,000USD | 253,816,000USD | 304,562,000USD |
| Net Working Capital | 1,810,712,000USD | 1,442,648,000USD | 1,800,884,000USD | 1,737,037,000USD | 1,826,945,000USD | 2,341,779,000USD | 1,985,880,000USD | 1,995,146,000USD |
| Unclassified Non Current Assets | 15,933,000USD | -9,520,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | 334,859,000USD | 283,288,000USD | 215,042,000USD | 214,419,000USD | 530,460,000USD | 517,473,000USD | 495,009,000USD | 468,601,000USD |
| Unclassified Equity | 6,051,226,000USD | 6,017,312,000USD | 5,961,415,000USD | 5,819,006,000USD | 5,801,151,000USD | 5,738,914,000USD | 5,588,829,000USD | 5,481,713,000USD |
| Short Term Debt | — | 11,393,000USD | 10,168,000USD | — | — | 13,473,000USD | 91,595,000USD | 91,505,000USD |
| Unclassified Current Liabilities | — | — | -10,168,000USD | 18,730,000USD | 79,864,000USD | 17,391,000USD | -76,899,000USD | -73,319,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 91,595,000USD | 91,505,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,349,703,000USD | 3,963,173,000USD | 3,264,576,000USD | 3,128,366,000USD | 3,147,974,000USD | 2,984,718,000USD | 1,822,822,000USD | 1,642,075,000USD |
| Intangible Assets | 28,949,000USD | 26,887,000USD | 29,620,000USD | 7,578,000USD | 14,239,000USD | 13,628,000USD | 12,497,000USD | 11,574,000USD |
| Other Current Assets | 163,934,000USD | 318,983,000USD | 143,247,000USD | 102,919,000USD | 6,142,000USD | 4,065,000USD | 78,848,000USD | 77,782,000USD |
| Total Liab | 2,209,081,000USD | 2,435,431,000USD | 2,405,239,000USD | 2,743,416,000USD | 2,219,965,000USD | 2,222,959,000USD | 1,004,635,000USD | 609,799,000USD |
| Total Stockholder Equity | 1,140,622,000USD | 1,527,742,000USD | 859,337,000USD | 384,950,000USD | 928,009,000USD | 761,759,000USD | 818,187,000USD | 1,032,276,000USD |
| Other Current Liab | 359,659,000USD | 356,122,000USD | 301,231,000USD | 406,475,000USD | 15,051,000USD | 22,139,000USD | 188,827,000USD | 2,463,000USD |
| Common Stock | 11,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 8,000USD | 7,000USD |
| Capital Stock | 11,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 8,000USD | 7,000USD |
| Retained Earnings | -4,876,984,000USD | -4,210,974,000USD | -4,446,213,000USD | -3,910,236,000USD | -3,206,748,000USD | -2,848,129,000USD | -2,294,001,000USD | -1,578,926,000USD |
| Cash | 801,282,000USD | 1,103,010,000USD | 428,430,000USD | 966,777,000USD | 2,115,869,000USD | 1,502,648,000USD | 835,080,000USD | 370,829,000USD |
| Cash And Short Term Investments | 939,650,000USD | 1,354,792,000USD | 1,676,250,000USD | 1,989,374,000USD | 2,115,869,000USD | 1,938,571,000USD | 1,124,748,000USD | 1,173,912,000USD |
| Total Current Assets | 2,537,938,000USD | 3,073,463,000USD | 2,579,331,000USD | 2,557,861,000USD | 2,604,099,000USD | 2,485,196,000USD | 1,468,913,000USD | 1,426,183,000USD |
| Total Current Liabilities | 1,095,290,000USD | 731,684,000USD | 653,659,000USD | 619,604,000USD | 452,733,000USD | 416,026,000USD | 264,767,000USD | 173,690,000USD |
| Current Deferred Revenue | 443,397,000USD | 130,256,000USD | 50,416,000USD | 89,244,000USD | 89,244,000USD | 89,244,000USD | 3,303,000USD | 3,303,000USD |
| Net Debt | 238,463,000USD | 240,060,000USD | 968,378,000USD | 650,582,000USD | -977,481,000USD | -429,788,000USD | -97,614,000USD | 49,725,000USD |
| Short Term Debt | 11,393,000USD | 13,473,000USD | 123,328,000USD | 15,489,000USD | 271,697,000USD | 193,553,000USD | 7,846,000USD | 134,095,000USD |
| Short Long Term Debt Total | 1,039,745,000USD | 1,343,070,000USD | 1,396,808,000USD | 1,617,359,000USD | 1,368,573,000USD | 1,186,046,000USD | 737,466,000USD | 554,649,000USD |
| Long Term Debt | 828,974,000USD | 1,137,124,000USD | 1,132,515,000USD | 1,544,292,000USD | 1,096,876,000USD | 992,493,000USD | 681,900,000USD | 420,554,000USD |
| Long Term Investments | 10,568,000USD | 136,873,000USD | 6,527,000USD | 31,321,000USD | 34,892,000USD | 38,799,000USD | 31,937,000USD | 107,294,000USD |
| Short Term Investments | 138,368,000USD | 251,782,000USD | 1,247,820,000USD | 1,022,597,000USD | 0USD | 435,923,000USD | 289,668,000USD | 803,083,000USD |
| Net Receivables | 519,610,000USD | 649,728,000USD | 436,975,000USD | 261,600,000USD | 171,637,000USD | 138,583,000USD | 93,938,000USD | 49,044,000USD |
| Inventory | 914,744,000USD | 749,960,000USD | 322,859,000USD | 203,968,000USD | 186,212,000USD | 231,961,000USD | 171,379,000USD | 125,445,000USD |
| Accounts Payable | 280,841,000USD | 214,442,000USD | 164,918,000USD | 95,875,000USD | 76,741,000USD | 111,090,000USD | 68,094,000USD | 33,829,000USD |
| Property Plant Equipment Net | 470,620,000USD | 488,646,000USD | 357,106,000USD | 244,991,000USD | 236,687,000USD | 282,191,000USD | 167,553,000USD | 97,024,000USD |
| Property Plant Equipment Gross | 751,535,000USD | 722,791,000USD | 548,076,000USD | 393,867,000USD | 349,319,000USD | 282,191,000USD | 167,553,000USD | 97,024,000USD |
| Accumulated Other Comprehensive Income | 272,000USD | -218,000USD | 918,000USD | -1,664,000USD | -20,000USD | 3,000USD | 50,000USD | -99,000USD |
| Common Stock Shares Outstanding | 104,793,000shares | 107,875,000shares | 92,398,000shares | 87,559,000shares | 81,262,000shares | 77,956,000shares | 73,615,000shares | 66,250,000shares |
| Non Current Assets Total | 811,765,000USD | 889,710,000USD | 685,245,000USD | 570,505,000USD | 543,875,000USD | 499,522,000USD | 353,908,999USD | 215,892,000USD |
| Non Current Liabilities Total | 1,113,791,000USD | 1,703,747,000USD | 1,751,580,000USD | 2,123,812,000USD | 1,767,232,000USD | 1,806,933,000USD | 739,867,999USD | 436,109,000USD |
| Non Current Liabilities Other | 1,529,000USD | 49,150,000USD | 41,100,000USD | 36,942,000USD | 670,356,000USD | 814,440,000USD | 57,968,000USD | 15,555,000USD |
| Non Currrent Assets Other | 311,148,000USD | 237,304,000USD | 291,992,000USD | 286,615,000USD | 143,285,000USD | 12,984,000USD | 132,355,999USD | 107,294,000USD |
| Net Working Capital | 1,442,648,000USD | 2,341,779,000USD | 1,925,672,000USD | 1,938,257,000USD | 2,151,366,000USD | 2,069,170,000USD | 1,204,146,000USD | 1,252,493,000USD |
| Unclassified Non Current Assets | -9,520,000USD | — | — | -286,615,000USD | -178,177,000USD | -143,544,000USD | -132,356,000USD | -182,849,000USD |
| Unclassified Non Current Liabilities | 283,288,000USD | 517,473,000USD | 577,965,000USD | — | -628,844,000USD | -734,073,000USD | -10,248,001USD | -15,555,000USD |
| Unclassified Equity | 6,017,312,000USD | 5,738,914,000USD | 5,304,614,000USD | 4,296,832,000USD | 4,134,759,000USD | 3,609,869,000USD | 3,112,122,000USD | 2,611,287,000USD |
| Unclassified Current Liabilities | — | 17,391,000USD | -91,717,000USD | 12,521,000USD | — | — | -3,303,000USD | — |
| Other Assets | — | — | 1USD | 286,615,000USD | 292,949,000USD | 295,464,000USD | 141,922,000USD | 75,555,000USD |
| Short Long Term Debt | — | — | 105,483,000USD | — | — | — | — | — |
| Other Liab | — | — | — | 521,942,000USD | 628,844,000USD | 734,073,000USD | 10,248,000USD | 15,555,000USD |
| Net Tangible Assets | — | — | — | 377,372,000USD | 913,770,000USD | 748,131,000USD | 805,690,000USD | 1,020,702,000USD |
| Unclassified Current Assets | — | — | — | — | 124,239,000USD | 172,016,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 330,959,000USD | -282,847,000USD | -179,947,000USD | 196,892,000USD | -447,508,000USD | 159,049,000USD | 33,611,000USD | 6,460,000USD |
| Depreciation | 10,594,000USD | 5,253,000USD | 18,450,000USD | 10,840,000USD | 9,978,000USD | 10,455,000USD | 9,806,000USD | 8,719,000USD |
| Stock Based Compensation | 29,399,000USD | 30,016,000USD | 14,927,000USD | 37,025,000USD | 41,428,000USD | 49,676,000USD | 43,450,000USD | 50,482,000USD |
| Other Non Cash Items | 12,616,000USD | 39,275,000USD | 161,213,000USD | -32,954,000USD | 94,442,000USD | -2,140,000USD | 59,057,000USD | -5,341,000USD |
| Change To Account Receivables | 3,416,000USD | -2,494,000USD | 131,556,000USD | 132,076,000USD | -57,383,000USD | -167,464,000USD | -74,527,000USD | 18,809,000USD |
| Change To Inventory | -69,756,000USD | 18,475,000USD | -83,020,000USD | -59,189,000USD | -177,359,000USD | -161,659,000USD | -70,539,000USD | -102,460,000USD |
| Change In Working Capital | -586,251,000USD | 339,509,000USD | -29,228,000USD | 49,534,000USD | -281,777,000USD | -124,994,000USD | -216,623,000USD | -45,378,000USD |
| Total Cash From Operating Activities | -202,683,000USD | 131,206,000USD | -14,585,000USD | 261,337,000USD | -583,437,000USD | 92,046,000USD | -70,699,000USD | 14,942,000USD |
| Capital Expenditures | -3,081,000USD | -5,829,000USD | -28,246,000USD | -31,984,000USD | -45,889,000USD | -38,082,000USD | -37,263,000USD | -29,167,000USD |
| Free Cash Flow | -205,764,000USD | 125,377,000USD | -42,831,000USD | 229,353,000USD | -629,326,000USD | 53,964,000USD | -107,962,000USD | -14,225,000USD |
| Investments | -131,309,000USD | -145,883,000USD | 232,400,000USD | 32,211,000USD | -291,177,000USD | 764,118,000USD | -128,825,000USD | -98,528,000USD |
| Total Cashflows From Investing Activities | -134,390,000USD | 96,207,000USD | 232,400,000USD | 32,211,000USD | -291,177,000USD | 764,118,000USD | -128,825,000USD | -98,528,000USD |
| Net Borrowings | 0USD | -35,133,000USD | -123,941,000USD | -304,000USD | -3,210,000USD | — | — | — |
| Total Cash From Financing Activities | 241,000USD | -39,208,000USD | -117,790,000USD | -23,817,000USD | 12,471,000USD | 48,991,000USD | 13,757,000USD | 39,918,000USD |
| Change In Cash | -336,832,000USD | 188,205,000USD | 100,025,000USD | 269,731,000USD | -862,143,000USD | 905,155,000USD | -185,767,000USD | -43,668,000USD |
| Begin Period Cash Flow | 801,282,000USD | 626,202,000USD | 526,177,000USD | 256,446,000USD | 1,118,589,000USD | 213,434,000USD | 399,201,000USD | 442,869,000USD |
| End Period Cash Flow | 464,450,000USD | 814,407,000USD | 626,202,000USD | 526,177,000USD | 256,446,000USD | 1,118,589,000USD | 213,434,000USD | 399,201,000USD |
| Other Cashflows From Investing Activities | -1,000,000USD | 241,250,000USD | -77,036,000USD | -188,000USD | -2,238,000USD | — | -10,000,000USD | -69,361,000USD |
| Other Cashflows From Financing Activities | 241,000USD | -4,273,000USD | -13,849,000USD | -23,817,000USD | 12,471,000USD | 48,991,000USD | 13,757,000USD | 39,918,000USD |
| Sale Purchase Of Stock | — | 0USD | 0USD | -25,013,000USD | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | 6,669,000USD | 105,282,000USD | 32,172,000USD | 48,127,000USD | 38,082,000USD | 47,263,000USD | 98,528,000USD |
| Unclassified Financing Cash Flow | — | — | 20,000,000USD | 25,317,000USD | 3,210,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -713,410,000USD | 235,239,000USD | -535,977,000USD | -703,488,000USD | -418,780,000USD | -554,128,000USD | -715,075,000USD | -361,918,000USD |
| Depreciation | 44,521,000USD | 37,724,000USD | 44,397,000USD | 41,864,000USD | 38,017,000USD | 26,911,000USD | 24,500,000USD | 12,245,000USD |
| Stock Based Compensation | 123,396,000USD | 184,300,000USD | 182,514,000USD | 233,018,000USD | 113,943,000USD | 108,070,000USD | 78,602,000USD | 50,127,000USD |
| Other Non Cash Items | 261,976,000USD | 53,556,000USD | 289,162,000USD | 142,730,000USD | -93,999,000USD | -38,085,000USD | 222,391,000USD | 20,190,000USD |
| Change To Account Receivables | 203,755,000USD | -201,661,000USD | -185,699,000USD | -61,638,000USD | -51,650,000USD | -10,461,000USD | -41,835,000USD | -19,576,000USD |
| Change To Inventory | -301,093,000USD | -395,170,000USD | -147,714,000USD | -50,780,000USD | -83,772,000USD | -60,582,000USD | -45,934,000USD | -41,840,000USD |
| Change In Working Capital | 78,038,000USD | -716,606,000USD | -481,089,000USD | -39,470,000USD | -98,166,000USD | 554,056,000USD | -66,881,000USD | -107,892,000USD |
| Total Cash From Operating Activities | -205,479,000USD | -205,787,000USD | -500,993,000USD | -325,346,000USD | -443,172,000USD | 107,466,000USD | -456,463,000USD | -388,660,000USD |
| Capital Expenditures | -101,972,000USD | -146,956,000USD | -87,345,000USD | -32,251,000USD | -38,490,000USD | -82,202,000USD | -59,631,000USD | -64,345,000USD |
| Free Cash Flow | -307,451,000USD | -352,743,000USD | -588,338,000USD | -357,597,000USD | -481,662,000USD | 25,264,000USD | -516,094,000USD | -453,005,000USD |
| Investments | 5,394,000USD | 755,561,000USD | -91,649,000USD | -1,046,883,000USD | 436,012,000USD | -144,088,000USD | 521,994,000USD | -305,790,000USD |
| Total Cashflows From Investing Activities | 69,641,000USD | 755,561,000USD | -165,803,000USD | -1,046,883,000USD | 495,413,000USD | -121,721,000USD | 286,725,000USD | -370,488,000USD |
| Net Borrowings | -162,588,000USD | -68,000USD | 0USD | 304,168,000USD | 304,168,000USD | 291,111,000USD | 244,936,000USD | -3,481,000USD |
| Total Cash From Financing Activities | -168,344,000USD | 124,806,000USD | 125,004,000USD | 232,507,000USD | 561,569,000USD | 682,323,000USD | 642,554,000USD | 530,150,000USD |
| Sale Purchase Of Stock | -25,013,000USD | 0USD | 0USD | — | -7,765,000USD | -4,798,000USD | -4,337,000USD | 563,631,000USD |
| Issuance Of Capital Stock | 20,000,000USD | 0USD | 0USD | 0USD | 548,532,000USD | 312,053,000USD | 365,354,000USD | 513,409,000USD |
| Change In Cash | -304,182,000USD | 674,580,000USD | -541,792,000USD | -1,139,722,000USD | 613,810,000USD | 668,068,000USD | 472,816,000USD | -228,998,000USD |
| Begin Period Cash Flow | 1,118,589,000USD | 444,009,000USD | 985,801,000USD | 2,125,523,000USD | 1,511,713,000USD | 843,645,000USD | 370,829,000USD | 599,827,000USD |
| End Period Cash Flow | 814,407,000USD | 1,118,589,000USD | 444,009,000USD | 985,801,000USD | 2,125,523,000USD | 1,511,713,000USD | 843,645,000USD | 370,829,000USD |
| Other Cashflows From Investing Activities | -253,695,000USD | -10,000,000USD | 90,761,000USD | -1,427,000USD | 97,891,000USD | 104,569,000USD | -3,082,000USD | -3,188,000USD |
| Other Cashflows From Financing Activities | -17,060,000USD | 124,874,000USD | 125,004,000USD | -71,661,000USD | 13,037,000USD | 79,120,000USD | 31,575,000USD | 563,631,000USD |
| Unclassified Investing Cash Flow | 419,914,000USD | 156,956,000USD | -77,570,000USD | 33,678,000USD | — | — | -172,556,000USD | — |
| Unclassified Financing Cash Flow | 36,317,000USD | — | — | — | 252,129,000USD | 603,203,000USD | 610,979,000USD | -593,631,000USD |
| Change To Liabilities | — | — | — | 58,328,000USD | -89,244,000USD | 749,429,000USD | 122,979,000USD | 90,162,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 613,810,000USD | 668,068,000USD | 472,816,000USD | -228,998,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 15,813,000USD | 10,642,000USD | — | — |
| Dividends Paid | — | — | — | — | — | -286,313,000USD | -240,599,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Elevidys | 101,965,000 | USD | 0001193125-26-208893 |
| Q1 2026Quarterly · 2026-03-31 | Product | Pmo Products | 228,550,000 | USD | 0001193125-26-208893 |
| Q4 2025Quarterly · 2025-12-31 | Product | Elevidys | 110,397,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Pmo Products | 259,210,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Elevidys | 898,731,000 | USD | 0001193125-26-084144 |
| FY 2025Yearly · 2025-12-31 | Product | Pmo Products | 965,565,000 | USD | 0001193125-26-084144 |
| Q3 2025Quarterly · 2025-09-30 | Product | Elevidys | 131,498,000 | USD | 0001193125-25-269436 |
| Q3 2025Quarterly · 2025-09-30 | Product | Pmo Products | 238,545,000 | USD | 0001193125-25-269436 |
| Q2 2025Quarterly · 2025-06-30 | Product | Elevidys | 281,851,000 | USD | 0000950170-25-103971 |
| Q2 2025Quarterly · 2025-06-30 | Product | Pmo Products | 231,272,000 | USD | 0000950170-25-103971 |
| Q1 2025Quarterly · 2025-03-31 | Product | Elevidys | 374,985,000 | USD | 0001193125-26-208893 |
| Q1 2025Quarterly · 2025-03-31 | Product | Pmo Products | 236,538,000 | USD | 0001193125-26-208893 |
| FY 2024Yearly · 2024-12-31 | Product | Elevidys | 820,791,000 | USD | 0001193125-26-084144 |
| FY 2024Yearly · 2024-12-31 | Product | Pmo Products | 967,169,000 | USD | 0001193125-26-084144 |
| Q3 2024Quarterly · 2024-09-30 | Product | Elevidys | 180,983,000 | USD | 0001193125-25-269436 |
| Q3 2024Quarterly · 2024-09-30 | Product | Pmo Products | 248,788,000 | USD | 0001193125-25-269436 |
| Q2 2024Quarterly · 2024-06-30 | Product | Elevidys | 121,721,000 | USD | 0000950170-25-103971 |
| Q2 2024Quarterly · 2024-06-30 | Product | Pmo Products | 238,827,000 | USD | 0000950170-25-103971 |
| Q4 2023Quarterly · 2023-12-31 | Product | Elevidys | 131,248,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Pmo Products | 233,823,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | Elevidys | 200,356,000 | USD | 0001193125-26-084144 |
| FY 2023Yearly · 2023-12-31 | Product | Pmo Products | 944,520,000 | USD | 0001193125-26-084144 |
| Q2 2023Quarterly · 2023-06-30 | Geography | International | 35,100,000 | USD | 0000950170-23-037125 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Other | 22,238,000 | USD | 0000950170-23-037125 |
| Q2 2023Quarterly · 2023-06-30 | Geography | United States | 203,900,000 | USD | 0000950170-23-037125 |
| Q1 2023Quarterly · 2023-03-31 | Geography | International | 31,000,000 | USD | 0000950170-23-016654 |
| Q1 2023Quarterly · 2023-03-31 | Geography | Other | 22,000,000 | USD | 0000950170-23-016654 |
| Q1 2023Quarterly · 2023-03-31 | Geography | United States | 200,500,000 | USD | 0000950170-23-016654 |
| FY 2022Yearly · 2022-12-31 | Product | Elevidys | 0 | USD | 0000950170-25-029973 |
| FY 2022Yearly · 2022-12-31 | Product | Pmo Products | 843,769,000 | USD | 0000950170-25-029973 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 96,700,000 | USD | 0000950170-23-005062 |
| FY 2022Yearly · 2022-12-31 | Geography | Other | 89,213,000 | USD | 0000950170-23-005062 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 747,100,000 | USD | 0000950170-23-005062 |
| Q2 2022Quarterly · 2022-06-30 | Geography | International | 23,600,000 | USD | 0000950170-23-037125 |
| Q2 2022Quarterly · 2022-06-30 | Geography | Other | 22,287,000 | USD | 0000950170-23-037125 |
| Q2 2022Quarterly · 2022-06-30 | Geography | United States | 187,600,000 | USD | 0000950170-23-037125 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.